FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042044265> ?p ?o ?g. }

• W2042044265 endingPage "706" @default.
• W2042044265 startingPage "706" @default.
• W2042044265 abstract "Patients with venous thromboembolism (VTE) are susceptible to recurrent events, but whether prolonging anticoagulation is warranted in patients with VTE remains controversial.To review the available evidence and quantify the risks and benefits of extending the duration of anticoagulation in patients with VTE.PubMed, EMBase Pharmacology, the Cochrane database, clinical trial Web sites, and a hand search of reference lists.Included studies were randomized controlled trials with results published from 1969 through 2004 and evaluating the duration of anticoagulation in patients with VTE that measured recurrent VTE. Excluded studies were those enrolling only pure populations of high-risk patients. Two independent reviewers assessed each article for inclusion and exclusion criteria, with adjudication by a third reviewer in cases of disagreement. Fifteen of 67 studies were included in the analysis.Two independent reviewers performed data extraction using a standardized form, with adjudication by the remainder of the investigators in cases of disagreement. Data regarding recurrent VTE, major bleeding, person-time at risk, and study quality were extracted.If patients in the long-term therapy group remained receiving anticoagulation, the risk of recurrent VTE with long- vs short-term therapy was reduced (weighted incidence rate, 0.020 vs 0.126 events/person-year; rate difference, -0.106 [95% confidence interval {CI}, -0.145 to -0.067]; P<.001; pooled incidence rate ratio [IRR], 0.21 [95% CI, 0.14 to 0.31]; P<.001). If anticoagulation in the long-term therapy group was discontinued, the risk reduction was less pronounced (weighted incidence rate, 0.052 vs 0.072 events/person-year; rate difference, -0.020 [95% CI, -0.039 to -0.001]; P = .04; pooled IRR, 0.69 [95% CI, 0.53 to 0.91]; P = .009). The risk of major bleeding with long- vs short-term therapy was similar (weighted incidence rate, 0.011 vs 0.006 events/person-year; rate difference, 0.005 [95% CI, -0.002 to 0.011]; P = .14; pooled IRR, 1.80 [95% CI, 0.72 to 4.51]; P = .21).Patients who receive extended anticoagulation are protected from recurrent VTE while receiving long-term therapy. The clinical benefit is maintained after anticoagulation is discontinued, but the magnitude of the benefit is less pronounced." @default.
• W2042044265 created "2016-06-24" @default.
• W2042044265 creator A5010055934 @default.
• W2042044265 creator A5023753488 @default.
• W2042044265 creator A5051205543 @default.
• W2042044265 creator A5063047369 @default.
• W2042044265 creator A5071078590 @default.
• W2042044265 creator A5076860890 @default.
• W2042044265 date "2005-08-10" @default.
• W2042044265 modified "2023-09-26" @default.
• W2042044265 title "Duration of Anticoagulation Following Venous Thromboembolism" @default.
• W2042044265 cites W1604622381 @default.
• W2042044265 cites W1933904409 @default.
• W2042044265 cites W1965476565 @default.
• W2042044265 cites W1983039462 @default.
• W2042044265 cites W1986215651 @default.
• W2042044265 cites W1986586255 @default.
• W2042044265 cites W1992159512 @default.
• W2042044265 cites W2009013630 @default.
• W2042044265 cites W2051556928 @default.
• W2042044265 cites W2058356320 @default.
• W2042044265 cites W2065472465 @default.
• W2042044265 cites W2073192852 @default.
• W2042044265 cites W2102535207 @default.
• W2042044265 cites W2112757583 @default.
• W2042044265 cites W2113989522 @default.
• W2042044265 cites W2134355273 @default.
• W2042044265 cites W2135918458 @default.
• W2042044265 cites W2137482796 @default.
• W2042044265 cites W2155288407 @default.
• W2042044265 cites W2169472792 @default.
• W2042044265 cites W2269058722 @default.
• W2042044265 cites W2316248832 @default.
• W2042044265 cites W2327974959 @default.
• W2042044265 cites W2331935930 @default.
• W2042044265 cites W2332640098 @default.
• W2042044265 cites W2568332688 @default.
• W2042044265 cites W2975554917 @default.
• W2042044265 cites W3174115521 @default.
• W2042044265 cites W55954674 @default.
• W2042044265 doi "https://doi.org/10.1001/jama.294.6.706" @default.
• W2042044265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16091573" @default.
• W2042044265 hasPublicationYear "2005" @default.
• W2042044265 type Work @default.
• W2042044265 sameAs 2042044265 @default.
• W2042044265 citedByCount "130" @default.
• W2042044265 countsByYear W20420442652012 @default.
• W2042044265 countsByYear W20420442652013 @default.
• W2042044265 countsByYear W20420442652014 @default.
• W2042044265 countsByYear W20420442652015 @default.
• W2042044265 countsByYear W20420442652016 @default.
• W2042044265 countsByYear W20420442652017 @default.
• W2042044265 countsByYear W20420442652018 @default.
• W2042044265 countsByYear W20420442652019 @default.
• W2042044265 countsByYear W20420442652020 @default.
• W2042044265 countsByYear W20420442652021 @default.
• W2042044265 countsByYear W20420442652022 @default.
• W2042044265 crossrefType "journal-article" @default.
• W2042044265 hasAuthorship W2042044265A5010055934 @default.
• W2042044265 hasAuthorship W2042044265A5023753488 @default.
• W2042044265 hasAuthorship W2042044265A5051205543 @default.
• W2042044265 hasAuthorship W2042044265A5063047369 @default.
• W2042044265 hasAuthorship W2042044265A5071078590 @default.
• W2042044265 hasAuthorship W2042044265A5076860890 @default.
• W2042044265 hasConcept C120665830 @default.
• W2042044265 hasConcept C121332964 @default.
• W2042044265 hasConcept C126322002 @default.
• W2042044265 hasConcept C167704817 @default.
• W2042044265 hasConcept C168563851 @default.
• W2042044265 hasConcept C17744445 @default.
• W2042044265 hasConcept C199539241 @default.
• W2042044265 hasConcept C207103383 @default.
• W2042044265 hasConcept C2779473830 @default.
• W2042044265 hasConcept C2780868729 @default.
• W2042044265 hasConcept C2991741193 @default.
• W2042044265 hasConcept C44249647 @default.
• W2042044265 hasConcept C61511704 @default.
• W2042044265 hasConcept C71924100 @default.
• W2042044265 hasConcept C82789193 @default.
• W2042044265 hasConcept C95190672 @default.
• W2042044265 hasConceptScore W2042044265C120665830 @default.
• W2042044265 hasConceptScore W2042044265C121332964 @default.
• W2042044265 hasConceptScore W2042044265C126322002 @default.
• W2042044265 hasConceptScore W2042044265C167704817 @default.
• W2042044265 hasConceptScore W2042044265C168563851 @default.
• W2042044265 hasConceptScore W2042044265C17744445 @default.
• W2042044265 hasConceptScore W2042044265C199539241 @default.
• W2042044265 hasConceptScore W2042044265C207103383 @default.
• W2042044265 hasConceptScore W2042044265C2779473830 @default.
• W2042044265 hasConceptScore W2042044265C2780868729 @default.
• W2042044265 hasConceptScore W2042044265C2991741193 @default.
• W2042044265 hasConceptScore W2042044265C44249647 @default.
• W2042044265 hasConceptScore W2042044265C61511704 @default.
• W2042044265 hasConceptScore W2042044265C71924100 @default.
• W2042044265 hasConceptScore W2042044265C82789193 @default.
• W2042044265 hasConceptScore W2042044265C95190672 @default.
• W2042044265 hasIssue "6" @default.
• W2042044265 hasLocation W20420442651 @default.

• next